One of Cytovance’s® core services is recombinant protein drug substance production derived from mammalian cell culture. Production processes formalized during process development are executed under cGMP in our state-of-the-art facility. The production team works in tandem with the tech transfer group to ensure a seamless transition from bench to clinic. Cell culture is scaled-up into our traditional stainless bioreactors or single-use bioreactors to meet a variety of process scales and requirements.
To learn more, visit: [ Ссылка ]
